{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T15:35:20Z","timestamp":1791819320889,"version":"4.3.4"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2017,2,27]],"date-time":"2017-02-27T00:00:00Z","timestamp":1488153600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Biotechnol"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1038\/nbt.3779","type":"journal-article","created":{"date-parts":[[2017,2,28]],"date-time":"2017-02-28T10:14:10Z","timestamp":1488276850000},"page":"230-237","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":582,"title":["Cellular uptake and trafficking of antisense oligonucleotides"],"prefix":"10.1038","volume":"35","author":[{"given":"Stanley T","family":"Crooke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy A","family":"Vickers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9333-8622","authenticated-orcid":false,"given":"Xue-hai","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,2,27]]},"reference":[{"key":"BFnbt3779_CR1","doi-asserted-by":"crossref","unstructured":"Crooke, S.T., Vickers, T., Lima, W. & Wu, H.-J. in Antisense Drug Technology\u2014Principles, Strategies, and Application 2nd edn. (ed. Crooke, S.T.) 3\u201346 (CRC Press, Boca Raton, FL, 2008).","DOI":"10.1201\/9780849387951.pt1"},{"key":"BFnbt3779_CR2","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.addr.2015.03.008","volume":"87","author":"MM Evers","year":"2015","unstructured":"Evers, M.M. & Toonen, L.J.A. & van Roon-Mom, W.M.C. Antisense oligonucleotides in therapy for neurodegenerative disorders. Adv. Drug Deliv. Rev. 87, 90\u2013103 (2015).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"BFnbt3779_CR3","doi-asserted-by":"crossref","first-page":"26801","DOI":"10.1016\/S0021-9258(18)47090-1","volume":"269","author":"DA Brown","year":"1994","unstructured":"Brown, D.A. et al. Effect of phosphorothioate modification of oligodeoxynucleotides on specific protein binding. J. Biol. Chem. 269, 26801\u201326805 (1994).","journal-title":"J. Biol. Chem."},{"key":"BFnbt3779_CR4","doi-asserted-by":"publisher","first-page":"2927","DOI":"10.1093\/nar\/gkv143","volume":"43","author":"XH Liang","year":"2015","unstructured":"Liang, X.H., Sun, H., Shen, W. & Crooke, S.T. Identification and characterization of intracellular proteins that bind oligonucleotides with phosphorothioate linkages. Nucleic Acids Res. 43, 2927\u20132945 (2015).","journal-title":"Nucleic Acids Res."},{"key":"BFnbt3779_CR5","doi-asserted-by":"crossref","unstructured":"Swayze, E.E. & Bhat, B. in Antisense Drug Technology\u2014Principles, Strategies, and Application 2nd edn. (ed. Crooke, S.T.) 143\u2013182 (CRC Press, Boca Raton, FL, 2008).","DOI":"10.1201\/9780849387951.ch6"},{"key":"BFnbt3779_CR6","unstructured":"Geary, R.S., Yu, R.Z., Siwkoswki, A. & Leivin, A.A. in Antisense Drug Technology\u2014Principles, Strategies, and Application 2nd edn. (ed. Crooke, S.T.) 305\u2013326 (CRC Press, Boca Raton, FL. 2008)."},{"key":"BFnbt3779_CR7","doi-asserted-by":"publisher","first-page":"347","DOI":"10.4161\/cbt.1.4.4","volume":"1","author":"N Dias","year":"2002","unstructured":"Dias, N. & Stein, C.A. Antisense oligonucleotides: basic concepts and mechanisms. Mol. Cancer Ther. 1, 347\u2013355 (2002).","journal-title":"Mol. Cancer Ther."},{"key":"BFnbt3779_CR8","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1046\/j.1432-1033.2003.03555.x","volume":"270","author":"J Kurreck","year":"2003","unstructured":"Kurreck, J. Antisense technologies. Improvement through novel chemical modifications. Eur. J. Biochem. 270, 1628\u20131644 (2003).","journal-title":"Eur. J. Biochem."},{"key":"BFnbt3779_CR9","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1007\/s12265-013-9495-7","volume":"6","author":"RG Lee","year":"2013","unstructured":"Lee, R.G., Crosby, J., Baker, B.F., Graham, M.J. & Crooke, R.M. Antisense technology: an emerging platform for cardiovascular disease therapeutics. J. Cardiovasc. Transl. Res. 6, 969\u2013980 (2013).","journal-title":"J. Cardiovasc. Transl. Res."},{"key":"BFnbt3779_CR10","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1146\/annurev.pharmtox.010909.105654","volume":"50","author":"CF Bennett","year":"2010","unstructured":"Bennett, C.F. & Swayze, E.E. RNA targeting therapeutics: molecular mechanisms of antisense oligonucleotides as a therapeutic platform. Annu. Rev. Pharmacol. Toxicol. 50, 259\u2013293 (2010).","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"BFnbt3779_CR11","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.addr.2015.01.008","volume":"87","author":"RS Geary","year":"2015","unstructured":"Geary, R.S., Norris, D., Yu, R. & Bennett, C.F. Pharmacokinetics, biodistribution and cell uptake of antisense oligonucleotides. Adv. Drug Deliv. Rev. 87, 46\u201351 (2015).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"BFnbt3779_CR12","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1111\/j.1471-4159.2004.02153.x","volume":"88","author":"B Tr\u00fclzsch","year":"2004","unstructured":"Tr\u00fclzsch, B. & Wood, M. Applications of nucleic acid technology in the CNS. J. Neurochem. 88, 257\u2013265 (2004).","journal-title":"J. Neurochem."},{"key":"BFnbt3779_CR13","doi-asserted-by":"publisher","first-page":"6518","DOI":"10.1093\/nar\/gkw236","volume":"44","author":"RL Juliano","year":"2016","unstructured":"Juliano, R.L. The delivery of therapeutic oligonucleotides. Nucleic Acids Res. 44, 6518\u20136548 (2016).","journal-title":"Nucleic Acids Res."},{"key":"BFnbt3779_CR14","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/S0079-6603(08)60279-2","volume":"57","author":"VV Vlassov","year":"1997","unstructured":"Vlassov, V.V., Vlassova, I.E. & Pautova, L.V. Oligonucleotides and polynucleotides as biologically active compounds. Prog. Nucleic Acid Res. Mol. Biol. 57, 95\u2013143 (1997).","journal-title":"Prog. Nucleic Acid Res. Mol. Biol."},{"key":"BFnbt3779_CR15","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1089\/ard.1992.2.211","volume":"2","author":"PL Iversen","year":"1992","unstructured":"Iversen, P.L., Zhu, S., Meyer, A. & Zon, G. Cellular uptake and subcellular distribution of phosphorothioate oligonucleotides into cultured cells. Antisense Res. Dev. 2, 211\u2013222 (1992).","journal-title":"Antisense Res. Dev."},{"key":"BFnbt3779_CR16","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1021\/bc100079n","volume":"21","author":"B Ugarte-Uribe","year":"2010","unstructured":"Ugarte-Uribe, B. et al. Synthesis, cell-surface binding, and cellular uptake of fluorescently labeled glucose-DNA conjugates with different carbohydrate presentation. Bioconjug. Chem. 21, 1280\u20131287 (2010).","journal-title":"Bioconjug. Chem."},{"key":"BFnbt3779_CR17","doi-asserted-by":"publisher","first-page":"6194","DOI":"10.1016\/j.biomaterials.2011.04.053","volume":"32","author":"CJ Cheng","year":"2011","unstructured":"Cheng, C.J. & Saltzman, W.M. Enhanced siRNA delivery into cells by exploiting the synergy between targeting ligands and cell-penetrating peptides. Biomaterials 32, 6194\u20136203 (2011).","journal-title":"Biomaterials"},{"key":"BFnbt3779_CR18","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1002\/dvg.1020140407","volume":"14","author":"C Yu","year":"1993","unstructured":"Yu, C., Brussaard, A.B., Yang, X., Listerud, M. & Role, L.W. Uptake of antisense oligonucleotides and functional block of acetylcholine receptor subunit gene expression in primary embryonic neurons. Dev. Genet. 14, 296\u2013304 (1993).","journal-title":"Dev. Genet."},{"key":"BFnbt3779_CR19","doi-asserted-by":"publisher","first-page":"4795","DOI":"10.1093\/nar\/gkr089","volume":"39","author":"E Koller","year":"2011","unstructured":"Koller, E. et al. Mechanisms of single-stranded phosphorothioate modified antisense oligonucleotide accumulation in hepatocytes. Nucleic Acids Res. 39, 4795\u20134807 (2011).","journal-title":"Nucleic Acids Res."},{"key":"BFnbt3779_CR20","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1089\/nat.2013.0463","volume":"24","author":"RL Juliano","year":"2014","unstructured":"Juliano, R.L., Ming, X., Carver, K. & Laing, B. Cellular uptake and intracellular trafficking of oligonucleotides: implications for oligonucleotide pharmacology. Nucleic Acid Ther. 24, 101\u2013113 (2014).","journal-title":"Nucleic Acid Ther."},{"key":"BFnbt3779_CR21","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3109\/1061186X.2012.740674","volume":"21","author":"RL Juliano","year":"2013","unstructured":"Juliano, R.L., Carver, K., Cao, C. & Ming, X. Receptors, endocytosis, and trafficking: the biological basis of targeted delivery of antisense and siRNA oligonucleotides. J. Drug Target. 21, 27\u201343 (2013).","journal-title":"J. Drug Target."},{"key":"BFnbt3779_CR22","unstructured":"Goldsack, N.C. et al. Integrin mediated uptake of antisense oligonucleotides to the PAR-1 thrombin receptor inhibits thrombin induced fibroblast proliferation. FASEB J. 12, A434 (1998)."},{"key":"BFnbt3779_CR23","doi-asserted-by":"publisher","first-page":"2764","DOI":"10.1093\/nar\/gkn115","volume":"36","author":"MR Alam","year":"2008","unstructured":"Alam, M.R. et al. Intracellular delivery of an anionic antisense oligonucleotide via receptor-mediated endocytosis. Nucleic Acids Res. 36, 2764\u20132776 (2008).","journal-title":"Nucleic Acids Res."},{"key":"BFnbt3779_CR24","doi-asserted-by":"publisher","first-page":"6567","DOI":"10.1093\/nar\/gkq534","volume":"38","author":"X Ming","year":"2010","unstructured":"Ming, X. et al. Intracellular delivery of an antisense oligonucleotide via endocytosis of a G-protein-coupled receptor. Nucleic Acids Res. 38, 6567\u20136576 (2010).","journal-title":"Nucleic Acids Res."},{"key":"BFnbt3779_CR25","doi-asserted-by":"publisher","first-page":"2782","DOI":"10.1093\/nar\/gkw112","volume":"44","author":"CM Miller","year":"2016","unstructured":"Miller, C.M. et al. Stabilin-1 and Stabilin-2 are specific receptors for the cellular internalization of phosphorothioate-modified antisense oligonucleotides (ASOs) in the liver. Nucleic Acids Res. 44, 2782\u20132794 (2016).","journal-title":"Nucleic Acids Res."},{"key":"BFnbt3779_CR26","doi-asserted-by":"publisher","first-page":"4364","DOI":"10.1021\/acs.nanolett.5b00490","volume":"15","author":"K Ezzat","year":"2015","unstructured":"Ezzat, K. et al. Self-Assembly into Nanoparticles Is Essential for Receptor Mediated Uptake of Therapeutic Antisense Oligonucleotides. Nano Lett. 15, 4364\u20134373 (2015).","journal-title":"Nano Lett."},{"key":"BFnbt3779_CR27","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1038\/nbt.1564","volume":"27","author":"M Kortylewski","year":"2009","unstructured":"Kortylewski, M. et al. In vivo delivery of siRNA to immune cells by conjugation to a TLR9 agonist enhances antitumor immune responses. Nat. Biotechnol. 27, 925\u2013932 (2009).","journal-title":"Nat. Biotechnol."},{"key":"BFnbt3779_CR28","doi-asserted-by":"publisher","first-page":"3947","DOI":"10.1093\/nar\/gkt078","volume":"41","author":"ER Kandimalla","year":"2013","unstructured":"Kandimalla, E.R. et al. Design, synthesis and biological evaluation of novel antagonist compounds of Toll-like receptors 7, 8 and 9. Nucleic Acids Res. 41, 3947\u20133961 (2013).","journal-title":"Nucleic Acids Res."},{"key":"BFnbt3779_CR29","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/0014-5793(95)00517-D","volume":"366","author":"DA Weidner","year":"1995","unstructured":"Weidner, D.A., Valdez, B.C., Henning, D., Greenberg, S. & Busch, H. Phosphorothioate oligonucleotides bind in a non-sequence-specific manner to the nucleolar protein C23\/nucleolin. FEBS Lett. 366, 146\u2013150 (1995).","journal-title":"FEBS Lett."},{"key":"BFnbt3779_CR30","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1089\/nat.2012.0347","volume":"22","author":"JW Kotula","year":"2012","unstructured":"Kotula, J.W. et al. Aptamer-mediated delivery of splice-switching oligonucleotides to the nuclei of cancer cells. Nucleic Acid Ther. 22, 187\u2013195 (2012).","journal-title":"Nucleic Acid Ther."},{"key":"BFnbt3779_CR31","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1038\/nbt.2614","volume":"31","author":"G Sahay","year":"2013","unstructured":"Sahay, G. et al. Efficiency of siRNA delivery by lipid nanoparticles is limited by endocytic recycling. Nat. Biotechnol. 31, 653\u2013658 (2013).","journal-title":"Nat. Biotechnol."},{"key":"BFnbt3779_CR32","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1038\/nbt.2612","volume":"31","author":"J Gilleron","year":"2013","unstructured":"Gilleron, J. et al. Image-based analysis of lipid nanoparticle-mediated siRNA delivery, intracellular trafficking and endosomal escape. Nat. Biotechnol. 31, 638\u2013646 (2013).","journal-title":"Nat. Biotechnol."},{"key":"BFnbt3779_CR33","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1172\/JCI117860","volume":"95","author":"C Beltinger","year":"1995","unstructured":"Beltinger, C. et al. Binding, uptake, and intracellular trafficking of phosphorothioate-modified oligodeoxynucleotides. J. Clin. Invest. 95, 1814\u20131823 (1995).","journal-title":"J. Clin. Invest."},{"key":"BFnbt3779_CR34","unstructured":"Bennett, C.F. in Antisense Drug Technology\u2014Principles, Strategies, and Application 2nd edn. (ed. Crooke, S.T.) 273\u2013304 (CRC Press, Boca Raton, FL, 2006)."},{"key":"BFnbt3779_CR35","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1093\/nar\/30.3.749","volume":"30","author":"TC Mou","year":"2002","unstructured":"Mou, T.C. & Gray, D.M. The high binding affinity of phosphorothioate-modified oligomers for Ff gene 5 protein is moderated by the addition of C-5 propyne or 2\u2032-O-methyl modifications. Nucleic Acids Res. 30, 749\u2013758 (2002).","journal-title":"Nucleic Acids Res."},{"key":"BFnbt3779_CR36","doi-asserted-by":"publisher","first-page":"3892","DOI":"10.1093\/nar\/gkw144","volume":"44","author":"XH Liang","year":"2016","unstructured":"Liang, X.H. et al. Hsp90 protein interacts with phosphorothioate oligonucleotides containing hydrophobic 2\u2032-modifications and enhances antisense activity. Nucleic Acids Res. 44, 3892\u20133907 (2016).","journal-title":"Nucleic Acids Res."},{"key":"BFnbt3779_CR37","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1021\/bc200377d","volume":"23","author":"RL Juliano","year":"2012","unstructured":"Juliano, R.L., Ming, X. & Nakagawa, O. Cellular uptake and intracellular trafficking of antisense and siRNA oligonucleotides. Bioconjug. Chem. 23, 147\u2013157 (2012).","journal-title":"Bioconjug. Chem."},{"key":"BFnbt3779_CR38","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.addr.2015.04.005","volume":"87","author":"RL Juliano","year":"2015","unstructured":"Juliano, R.L. & Carver, K. Cellular uptake and intracellular trafficking of oligonucleotides. Adv. Drug Deliv. Rev. 87, 35\u201345 (2015).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"BFnbt3779_CR39","doi-asserted-by":"publisher","first-page":"8617","DOI":"10.1158\/0008-5472.CAN-10-0920","volume":"70","author":"EM Reyes-Reyes","year":"2010","unstructured":"Reyes-Reyes, E.M., Teng, Y. & Bates, P.J. A new paradigm for aptamer therapeutic AS1411 action: uptake by macropinocytosis and its stimulation by a nucleolin-dependent mechanism. Cancer Res. 70, 8617\u20138629 (2010).","journal-title":"Cancer Res."},{"key":"BFnbt3779_CR40","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1089\/oli.2009.0211","volume":"20","author":"MR Alam","year":"2010","unstructured":"Alam, M.R. et al. The biological effect of an antisense oligonucleotide depends on its route of endocytosis and trafficking. Oligonucleotides 20, 103\u2013109 (2010).","journal-title":"Oligonucleotides"},{"issue":"1","key":"BFnbt3779_CR41","doi-asserted-by":"publisher","first-page":"e3","DOI":"10.1093\/nar\/gkp841","volume":"38","author":"C. A. Stein","year":"2009","unstructured":"Stein, C.A. et al. Efficient gene silencing by delivery of locked nucleic acid antisense oligonucleotides, unassisted by transfection reagents. Nucleic Acids Res. 38 e3 (2010).","journal-title":"Nucleic Acids Research"},{"key":"BFnbt3779_CR42","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.jconrel.2011.04.029","volume":"153","author":"X Ming","year":"2011","unstructured":"Ming, X., Sato, K. & Juliano, R.L. Unconventional internalization mechanisms underlying functional delivery of antisense oligonucleotides via cationic lipoplexes and polyplexes. J. Control. Release 153, 83\u201392 (2011).","journal-title":"J. Control. Release"},{"key":"BFnbt3779_CR43","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1124\/mol.53.2.262","volume":"53","author":"EA Biessen","year":"1998","unstructured":"Biessen, E.A., Vietsch, H., Kuiper, J., Bijsterbosch, M.K. & Berkel, T.J. Liver uptake of phosphodiester oligodeoxynucleotides is mediated by scavenger receptors. Mol. Pharmacol. 53, 262\u2013269 (1998).","journal-title":"Mol. Pharmacol."},{"key":"BFnbt3779_CR44","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1038\/mt.2013.54","volume":"21","author":"A El-Sayed","year":"2013","unstructured":"El-Sayed, A. & Harashima, H. Endocytosis of gene delivery vectors: from clathrin-dependent to lipid raft-mediated endocytosis. Mol. Ther. 21, 1118\u20131130 (2013).","journal-title":"Mol. Ther."},{"key":"BFnbt3779_CR45","doi-asserted-by":"publisher","first-page":"8796","DOI":"10.1093\/nar\/gku531","volume":"42","author":"TP Prakash","year":"2014","unstructured":"Prakash, T.P. et al. Targeted delivery of antisense oligonucleotides to hepatocytes using triantennary N-acetyl galactosamine improves potency 10-fold in mice. Nucleic Acids Res. 42, 8796\u20138807 (2014).","journal-title":"Nucleic Acids Res."},{"key":"BFnbt3779_CR46","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.jconrel.2016.02.007","volume":"226","author":"S Wada","year":"2016","unstructured":"Wada, S. et al. Evaluation of the effects of chemically different linkers on hepatic accumulations, cell tropism and gene silencing ability of cholesterol-conjugated antisense oligonucleotides. J. Control. Release 226, 57\u201365 (2016).","journal-title":"J. Control. Release"},{"key":"BFnbt3779_CR47","doi-asserted-by":"publisher","first-page":"e0161930","DOI":"10.1371\/journal.pone.0161930","volume":"11","author":"TA Vickers","year":"2016","unstructured":"Vickers, T.A. & Crooke, S.T. Development of a quantitative BRET affinity assay for nucleic acid-protein interactions. PLoS One 11, e0161930 (2016).","journal-title":"PLoS One"},{"key":"BFnbt3779_CR48","first-page":"7314","volume":"44","author":"S Wang","year":"2016","unstructured":"Wang, S., Sun, H., Tanowitz, M., Liang, X.H. & Crooke, S.T. Annexin A2 facilitates endocytic trafficking of antisense oligonucleotides. Nucleic Acids Res. 44, 7314\u20137330 (2016).","journal-title":"Nucleic Acids Res."},{"key":"BFnbt3779_CR49","doi-asserted-by":"publisher","first-page":"8648","DOI":"10.1093\/nar\/gku579","volume":"42","author":"W Shen","year":"2014","unstructured":"Shen, W., Liang, X.H. & Crooke, S.T. Phosphorothioate oligonucleotides can displace NEAT1 RNA and form nuclear paraspeckle-like structures. Nucleic Acids Res. 42, 8648\u20138662 (2014).","journal-title":"Nucleic Acids Res."},{"key":"BFnbt3779_CR50","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1021\/acschembio.5b00143","volume":"10","author":"T Machleidt","year":"2015","unstructured":"Machleidt, T. et al. NanoBRET\u2014a novel BRET platform for the analysis of protein-protein interactions. ACS Chem. Biol. 10, 1797\u20131804 (2015).","journal-title":"ACS Chem. Biol."},{"key":"BFnbt3779_CR51","first-page":"1091","volume":"2","author":"DJ Chin","year":"1990","unstructured":"Chin, D.J., Green, G.A., Zon, G., Szoka, F.C. Jr. & Straubinger, R.M. Rapid nuclear accumulation of injected oligodeoxyribonucleotides. New Biol. 2, 1091\u20131100 (1990).","journal-title":"New Biol."},{"key":"BFnbt3779_CR52","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S0026-895X(25)09229-6","volume":"41","author":"CF Bennett","year":"1992","unstructured":"Bennett, C.F., Chiang, M.Y., Chan, H., Shoemaker, J.E. & Mirabelli, C.K. Cationic lipids enhance cellular uptake and activity of phosphorothioate antisense oligonucleotides. Mol. Pharmacol. 41, 1023\u20131033 (1992).","journal-title":"Mol. Pharmacol."},{"key":"BFnbt3779_CR53","doi-asserted-by":"publisher","first-page":"2702","DOI":"10.1073\/pnas.88.7.2702","volume":"88","author":"JP Leonetti","year":"1991","unstructured":"Leonetti, J.P., Mechti, N., Degols, G., Gagnor, C. & Lebleu, B. Intracellular distribution of microinjected antisense oligonucleotides. Proc. Natl. Acad. Sci. USA 88, 2702\u20132706 (1991).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnbt3779_CR54","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1091\/mbc.9.5.1007","volume":"9","author":"P Lorenz","year":"1998","unstructured":"Lorenz, P., Baker, B.F., Bennett, C.F. & Spector, D.L. Phosphorothioate antisense oligonucleotides induce the formation of nuclear bodies. Mol. Biol. Cell 9, 1007\u20131023 (1998).","journal-title":"Mol. Biol. Cell"},{"key":"BFnbt3779_CR55","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1093\/nar\/28.2.582","volume":"28","author":"P Lorenz","year":"2000","unstructured":"Lorenz, P., Misteli, T., Baker, B.F., Bennett, C.F. & Spector, D.L. Nucleocytoplasmic shuttling: a novel in vivo property of antisense phosphorothioate oligodeoxynucleotides. Nucleic Acids Res. 28, 582\u2013592 (2000).","journal-title":"Nucleic Acids Res."},{"key":"BFnbt3779_CR56","doi-asserted-by":"publisher","first-page":"7819","DOI":"10.1093\/nar\/gku484","volume":"42","author":"XH Liang","year":"2014","unstructured":"Liang, X.H., Shen, W., Sun, H., Prakash, T.P. & Crooke, S.T. TCP1 complex proteins interact with phosphorothioate oligonucleotides and can co-localize in oligonucleotide-induced nuclear bodies in mammalian cells. Nucleic Acids Res. 42, 7819\u20137832 (2014).","journal-title":"Nucleic Acids Res."},{"key":"BFnbt3779_CR57","doi-asserted-by":"publisher","first-page":"2016","DOI":"10.1093\/nar\/26.8.2016","volume":"26","author":"EG Marcusson","year":"1998","unstructured":"Marcusson, E.G., Bhat, B., Manoharan, M., Bennett, C.F. & Dean, N.M. Phosphorothioate oligodeoxyribonucleotides dissociate from cationic lipids before entering the nucleus. Nucleic Acids Res. 26, 2016\u20132023 (1998).","journal-title":"Nucleic Acids Res."},{"key":"BFnbt3779_CR58","doi-asserted-by":"publisher","first-page":"11493","DOI":"10.1073\/pnas.93.21.11493","volume":"93","author":"O Zelphati","year":"1996","unstructured":"Zelphati, O. & Szoka, F.C. Jr. Mechanism of oligonucleotide release from cationic liposomes. Proc. Natl. Acad. Sci. USA 93, 11493\u201311498 (1996).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnbt3779_CR59","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1016\/j.febslet.2005.01.041","volume":"579","author":"I Tarkanyi","year":"2005","unstructured":"Tarkanyi, I. et al. Inhibition of human telomerase by oligonucleotide chimeras, composed of an antisense moiety and a chemically modified homo-oligonucleotide. FEBS Lett. 579, 1411\u20131416 (2005).","journal-title":"FEBS Lett."},{"key":"BFnbt3779_CR60","doi-asserted-by":"publisher","first-page":"9350","DOI":"10.1093\/nar\/gkv964","volume":"43","author":"D Castanotto","year":"2015","unstructured":"Castanotto, D. et al. A cytoplasmic pathway for gapmer antisense oligonucleotide-mediated gene silencing in mammalian cells. Nucleic Acids Res. 43, 9350\u20139361 (2015).","journal-title":"Nucleic Acids Res."},{"key":"BFnbt3779_CR61","doi-asserted-by":"publisher","first-page":"3257","DOI":"10.1039\/b507691a","volume":"3","author":"T Kubo","year":"2005","unstructured":"Kubo, T. et al. Controlled intracellular localization and enhanced antisense effect of oligonucleotides by chemical conjugation. Org. Biomol. Chem. 3, 3257\u20133259 (2005).","journal-title":"Org. Biomol. Chem."},{"key":"BFnbt3779_CR62","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1021\/mp900093r","volume":"6","author":"R Juliano","year":"2009","unstructured":"Juliano, R., Bauman, J., Kang, H. & Ming, X. Biological barriers to therapy with antisense and siRNA oligonucleotides. Mol. Pharm. 6, 686\u2013695 (2009).","journal-title":"Mol. Pharm."},{"key":"BFnbt3779_CR63","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1093\/nar\/gkv060","volume":"43","author":"B Yang","year":"2015","unstructured":"Yang, B. et al. High-throughput screening identifies small molecules that enhance the pharmacological effects of oligonucleotides. Nucleic Acids Res. 43, 1987\u20131996 (2015).","journal-title":"Nucleic Acids Res."},{"key":"BFnbt3779_CR64","doi-asserted-by":"publisher","first-page":"e108625","DOI":"10.1371\/journal.pone.0108625","volume":"9","author":"TA Vickers","year":"2014","unstructured":"Vickers, T.A. & Crooke, S.T. Antisense oligonucleotides capable of promoting specific target mRNA reduction via competing RNase H1-dependent and independent mechanisms. PLoS One 9, e108625 (2014).","journal-title":"PLoS One"}],"container-title":["Nature Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nbt.3779.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nbt.3779","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nbt.3779.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,15]],"date-time":"2025-06-15T17:26:35Z","timestamp":1750008395000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nbt.3779"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,27]]},"references-count":64,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["BFnbt3779"],"URL":"https:\/\/doi.org\/10.1038\/nbt.3779","relation":{},"ISSN":["1087-0156","1546-1696"],"issn-type":[{"value":"1087-0156","type":"print"},{"value":"1546-1696","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,27]]},"assertion":[{"value":"7 June 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This work was funded by Ionis Pharmaceuticals. All authors are employees of Ionis Pharmaceuticals.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}